Ziprasidone-induced sub acute cutaneous lupus erythematosus

Abstract

View all access options for this article.

Marzano

Lazzari

Polloni

. Drug-induced sub acute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart. Br J Dermatol 2011; 165: 335–341.

Lowe

Henderson

Grau

. A systematic review of drug-induced sub acute cutaneous lupus erythematosus. Br J Dermatol 2011; 164: 465–472.

Swensen

Ravasia

. Ziprasidone-induced lupus erythematosus. Can J Psychiatry 2004; 49: 413–414.

Hejazi

Werth

. Cutaneous lupus erythematosus: an update on pathogenesis, diagnosis and treatment. Am J Clin Dermatol 2016; 17: 135–146.

Srivastava

Rencic

Diglio

. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol 2003; 139: 45–49.

Pretel

Marquès

España

. Drug-induced lupus erythematosus. Actas Dermosifiliogr 2014; 105: 18–30.

Callen

. Drug-induced sub acute cutaneous lupus erythematosus – filling the gap in knowledge. JAMA Dermatol 2013; 149: 1075–1076.

Marzano

Vezzoli

Crosti

. Drug-induced lupus: an update on its dermatologic aspects. Lupus 2009; 18: 935–940.